High LDL Cholesterol, Low Risk? Lean Mass Hyper-responder phenotype – A literature review
DOI:
https://doi.org/10.12775/QS.2025.43.61260Keywords
Lean mass hyper-responder, Carbohydrate-restrictive diets, Lipid profile, LDL Cholesterol, Cardiovascular risk, Lipid Energy ModelAbstract
Introduction:
The Lean Mass Hyper-Responder (LMHR) phenotype is a distinct lipid profile observed in individuals following carbohydrate-restrictive diets (CRDs), such as ketogenic or carnivore diets. This phenotype is characterized by markedly elevated low-density lipoprotein cholesterol (LDL-C), high high-density lipoprotein cholesterol (HDL-C), and low triglycerides (TG). Understanding the mechanisms and clinical implications of LMHR is crucial given its potential impact on cardiovascular risk assessment.
Materials and methods:
We reviewed recent studies investigating the epidemiology, metabolic mechanisms, and clinical outcomes of the LMHR phenotype. Particular focus was given to the Lipid Energy Model hypothesis and coronary computed tomography angiography findings.
Results:
The LMHR phenotype presents with LDL-C >200 mg/dL, HDL-C >80 mg/dL, and TG <70 mg/dL, differing from classical atherogenic dyslipidemia. The Lipid Energy Model suggests that increased reliance on triglyceride-rich lipoproteins as an energy source underlies these lipid alterations. Observational data show no significant difference in plaque burden or progression between LMHR individuals and matched controls, despite elevated LDL-C levels. Results from large dietary studies present no significant correlation between CVD and following carbohydrate restriction, which further supports the hypothesis and points out the necessity of the intensive research in this field.
Conclusions:
While elevated LDL-C traditionally indicates increased cardiovascular risk, current evidence suggests heterogeneity within the LMHR population, with no clear correlation between high LDL-C and atherosclerotic progression. Long-term prospective studies are needed to clarify the clinical significance of this phenotype and guide risk assessment in individuals on CRD.
References
1. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA. 1986 Nov 28;256(20):2835–2838. https://pubmed.ncbi.nlm.nih.gov/3773200/
2. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 Mar 5;105(9):1135–1143. https://doi.org/10.1161/hc0902.104353
3. Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999 Jan 14;340(2):115–126. https://doi.org/10.1056/NEJM199901143400207
4. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Aug 30;42(34):3227–337. https://doi.org/10.1093/eurheartj/ehab484
5. Norwitz NG, Soto‑Mota A, Kaplan B, Ludwig DS, Budoff M, Kontush A, et al. The Lipid Energy Model: reimagining lipoprotein function in the context of carbohydrate‑restricted diets. Metabolites. 2022 May 20;12(5):460. https://doi.org/10.3390/metabo12050460
6. Burén J, Ericsson M, Damasceno N, Sjödin A. A ketogenic low‑carbohydrate high‑fat diet increases LDL cholesterol in healthy, young, normal‑weight women: a randomized controlled feeding trial. Nutrients. 2021 Mar 2;13(3):814. https://doi.org/10.3390/nu13030814
7. Nakanishi R, Ceponiene I, Osawa K, Luo Y, Kanisawa M, Megowan N, et al. Plaque progression assessed by a novel semi‑automated quantitative plaque software on coronary computed tomography angiography between diabetes and non‑diabetes patients: a propensity‑score matching study. Atherosclerosis. 2016 Dec;255:73–79. https://doi.org/10.1016/j.atherosclerosis.2016.11.004
8. Retterstøl K, Svendsen M, Narverud I, Holven KB. Effect of low carbohydrate high fat diet on LDL cholesterol and gene expression in normal‑weight, young adults: a randomized controlled study. Atherosclerosis. 2018 Dec;279:52–61. https://doi.org/10.1016/j.atherosclerosis.2018.10.013
9. Norwitz NG, Feldman D, Soto‑Mota A, Kalayjian T, Ludwig DS. Elevated LDL cholesterol with a carbohydrate‑restricted diet: evidence for a “lean mass hyper‑responder” phenotype. Curr Dev Nutr. 2022 Jan;6(1):nzab144. https://doi.org/10.1093/cdn/nzab144
10. Budoff M, Manubolu VS, Kinninger A, Norwitz NG, Feldman D, Wood TR, et al. Carbohydrate restriction‑induced elevations in LDL‑cholesterol and atherosclerosis. JACC Adv. 2024 Aug;3(8):101109. https://doi.org/10.1016/j.jacadv.2024.101109
11. Javier DAR, Manubolu VS, Norwitz NG, Kinninger A, Aldana‑Bitar J, Ghanem A, et al. The impact of carbohydrate restriction‑induced elevations in low‑density lipoprotein cholesterol on progression of coronary atherosclerosis: the ketogenic diet trial study design. Coron Artery Dis. 2024 Jun 13;35(7):577–583. https://doi.org/10.1097/mca.0000000000001395
12. Vaezi Z, Amini A. Familial hypercholesterolemia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. https://pubmed.ncbi.nlm.nih.gov/32310469/
13. Soto‑Mota A, Flores‑Jurado Y, Norwitz NG, Feldman D, Pereira MA, Danaei G, et al. Increased low‑density lipoprotein cholesterol on a low‑carbohydrate diet in adults with normal but not high body weight: a meta‑analysis. Am J Clin Nutr. 2024 Mar;119(3):740–747. https://doi.org/10.1016/j.ajcnut.2024.01.009
14. Pirahanchi Y, Anoruo M, Sharma S. Biochemistry, lipoprotein lipase. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. https://pubmed.ncbi.nlm.nih.gov/30725725/
15. Norwitz NG, Cromwell WC. Oreo Cookie Treatment lowers LDL cholesterol more than high‑intensity statin therapy in a lean mass hyper‑responder on a ketogenic diet: a curious crossover experiment. Metabolites. 2024 Jan 22;14(1):73. https://doi.org/10.3390/metabo14010073
16. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low‑density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017 Apr 24;38(32):2459–2472. https://doi.org/10.1093/eurheartj/ehx144
17. Burger PM, Dorresteijn JAN, Koudstaal S, Holtrop J, Kastelein JJP, Jukema JW, et al. Course of the effects of LDL‑cholesterol reduction on cardiovascular risk over time: a meta‑analysis of 60 randomized controlled trials. Atherosclerosis. 2024 Sep;396:118540. https://doi.org/10.1016/j.atherosclerosis.2024.118540
18. Soto‑Mota A, Norwitz NG, Manubolu VS, Kinninger A, Wood TR, Earls J, et al. Plaque begets plaque, ApoB does not. JACC Adv. 2025 Apr;101686. https://doi.org/10.1016/j.jacadv.2025.101686
19. Han D, Berman DS, Miller RJH, Andreini D, Budoff MJ, Cademartiri F, et al. Association of cardiovascular disease risk factor burden with progression of coronary atherosclerosis assessed by serial coronary computed tomographic angiography. JAMA Netw Open. 2020 Jul 24;3(7):e2011444. https://doi.org/10.1001/jamanetworkopen.2020.11444
20. van Rosendael SE, van den Hoogen IJ, Lin FY, Andreini D, Al‑Mallah MH, Budoff MJ, et al. Clinical and coronary plaque predictors of atherosclerotic nonresponse to statin therapy. JACC Cardiovasc Imaging. 2023 Apr;16(4):495–504. https://doi.org/10.1016/j.jcmg.2022.10.017
21. Talley JT, Mohiuddin SS. Biochemistry, fatty acid oxidation. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan‑. https://www.ncbi.nlm.nih.gov/books/NBK556002/
22. Noto H, Goto A, Tsujimoto T, Noda M. Low‑carbohydrate diets and all‑cause mortality: a systematic review and meta‑analysis of observational studies. PLoS ONE. 2013 Jan 25;8(1):e55030. https://doi.org/10.1371/journal.pone.0055030
23. Seidelmann SB, Claggett B, Cheng S, Henglin M, Shah A, Steffen LM, et al. Dietary carbohydrate intake and mortality: a prospective cohort study and meta‑analysis. Lancet Public Health. 2018 Sep;3(9):e419–e428. https://doi.org/10.1016/S2468-2667(18)30135-X
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jakub Mierzejewski, Adam Rafałowicz, Urszula Justyna Wojciechowska

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 28
Number of citations: 0